Atogepant is under investigation in clinical trial NCT03855137 (Efficacy, Safety, and Tolerability of Atogepant for the Prevention of Chronic Migraine). Reference standards of Atogepant API, and its pharmacopeial, non pharmacopeial impurities, and stable isotopes are listed below.
Atogepant
Catalogue No.:PA 01 3310000
CAS :
Molecular Formula : C29H23F6N5O3
Molecular Weight : 603.53
Tert-butyl ((5S,6R)-6-methyl-2-oxo-5-(2,3,6-trifluorophenyl)piperidin-3-yl)carbamate
Catalogue No.:PA 01 3311000
Molecular Formula : C17H21F3N2O3
Molecular Weight : 358.36
Isopropyl 2-((tert-butoxycarbonyl)amino)-5-oxo-4-(2,3,6-trifluorophenyl)hexanoate
Catalogue No.:PA 01 3311001
Molecular Formula : C20H26F3NO5
Molecular Weight : 417.43
rel-(3′R)-1′,2′,5,7-Tetrahydro-N-[(3R,5R,6S)-6-methyl-2-oxo-1-(2,2,2-trifluoroethyl)-5-(2,3,6-trifluorophenyl)-3-piperidinyl]-2′-oxospiro[6H-cyclopenta[b]pyridine-6,3′-[3H]pyrrolo[2,3-b]pyridine]-3-carboxamide
Catalogue No.:PA 01 3311002
N-((3S,5S,6R)-6-Methyl-2-oxo-1-(2,2,2-trifluoroethyl)-5-(2,3,6-trifluorophenyl)piperidin-3-yl)acetamide
Catalogue No.:PA 01 3311003
Molecular Formula : C16H16F6N2O2
Molecular Weight : 382.31
(S)-2'-Oxo-1',2',5,7-tetrahydrospiro[cyclopenta[b]pyridine-6,3'-pyrrolo[2,3-b]pyridine]-3-carboxylic Acid
Catalogue No.:PA 01 3311004
Molecular Formula : C15H11N3O3
Molecular Weight : 281.27
(S)-2-Acetamido-N-((3S,5S,6R)-6-methyl-2-oxo-1-(2,2,2-trifluoroethyl)-5-(2,3,6-trifluorophenyl)piperidin-3-yl)-3-phenylpropanamide
Catalogue No.:PA 01 3311005
Molecular Formula : C25H25F6N3O3
Molecular Weight : 529.48
(3S,5S,6R)-3-Amino-6-methyl-1-(2,2,2-trifluoroethyl)-5-(2,3,6-trifluorophenyl)piperidin-2-one
Catalogue No.:PA 01 3311006
Molecular Formula : C14H14F6N2O
Molecular Weight : 340.27
(S)-N-((3S,5S,6R)-6-Methyl-2-oxo-5-(2,3,6-trifluorophenyl)piperidin-3-yl)-2'-oxo-1',2',5,7-tetrahydrospiro[cyclopenta[b]pyridine-6,3'-pyrrolo[2,3-b]pyridine]-3-carboxamide
Catalogue No.:PA 01 3311007
Molecular Formula : C27H22F3N5O3
Molecular Weight : 521.5
Methyl (S)-2'-oxo-1',2',5,7-tetrahydrospiro[cyclopenta[b]pyridine-6,3'-pyrrolo[2,3-b]pyridine]-3-carboxylate
Catalogue No.:PA 01 3311008
Molecular Formula : C16H13N3O3
Molecular Weight : 295.3
(S)-N-((3R,5S,6R)-6-Methyl-2-oxo-1-(2,2,2-trifluoroethyl)-5-(2,3,6-trifluorophenyl)piperidin-3-yl)-2'-oxo-1',2',5,7-tetrahydrospiro[cyclopenta[b]pyridine-6,3'-pyrrolo[2,3-b]pyridine]-3-carboxamide
Catalogue No.:PA 01 3311009
(S)-N-((3S,5S,6S)-6-Methyl-2-oxo-1-(2,2,2-trifluoroethyl)-5-(2,3,6-trifluorophenyl)piperidin-3-yl)-2'-oxo-1',2',5,7-tetrahydrospiro[cyclopenta[b]pyridine-6,3'-pyrrolo[2,3-b]pyridine]-3-carboxamide
Catalogue No.:PA 01 3311010
I accept terms and conditions
Message sent successfully!! We will get back to you shortly ....
